It has been suggested that low body weight may be associated with decreased respiratory muscle function in COPD, but the precise mechanism is not known. Since body compositional change inevitably accompanies body weight change, we decided to study the possible relationship between respiratory muscle strength and body composition in patients with COPD. We studied respiratory muscle strength, pulmonary function, and body composition in 24 Japanese male patients with COPD. Patients were divided into two groups according to their body weight ( ness attracted us to initiate this study. First we studied which body component is affected most in patients with COPD with low body weight and then studied whether this component has an association with respiratory muscle weakness. We found that lean body mass appears to be affected in patients with COPD with low body weight and the parameters of respiratory muscle function seem to be closely related to this particular component of the body. Therefore, we propose that lean body mass loss that manifests itself as body weight loss may be an important contributing factor for respiratory muscle weakness in patients with COPD.
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METHODS

Subjects
We studied in 24 male patients with COPD. Diagnostic crite- Two milliliters of arterial blood were sampled anaerobically from the brachial artery while the patient breathed room air, and the blood was quickly analyzed to obtain arterial oxygen tension (PaO2), arterial carbon dioxide tension (PaCO2), and pH with a pH blood gas analyzer (model 213, Instrumentation Laboratories; Lexington, Mass.).
Body Compositional Measurement
Body composition was measured by DXA (XR-26, Norland) using whole-body absorptiometry software version 2.0.1. Principles involved in DXA analysis of body composition were recently reviewed.'0 Briefly, unattenuated photon flux is recorded for each energy in air prior to the measurement and stored in the computer memory; then the patient is scanned and attenuated photon flux is recorded on a pixel-by-pixel basis for both energies as the photon beam scans the patients in a rectilinear fashion. Bone mineral content and soft-tissue mass that is partitioned into fat mass (FAT) and nonfat, lean mass (LEAN) was calculated separately based on its difference in mass attenuation coefficients." The patient disrobed completely and put on a cotton gown so that no artificial density was added during body composition analysis. The patient then lay down on the patient pad in a supine position and his/her whole body was scanned by the scanner. It usually takes about 15 min to complete the whole analysis. Each value of the body composition was expressed as kilograms. The percentage of BMC, LEAN, and FAT was calculated by dividing each absolute value of body composition by total body mass, and expressed as %BMC, %LEAN, and %FAT, respectively. Body mass index (BMI) was calculated by dividing body weight (kg) by squared body height (m2).
Statistical Analyses
All values are given as mean + SD. Statistical differences for variables of respiratory muscle strength and pulmonary function were analyzed by analysis of variance. Correlation analysis was performed between parameters of respiratory muscle strength and body composition. Values of p<0.05 were considered to be statistically significant.
RESULTS
Age, Body Height, Body Weight, and BMI As shown in Table 1 , there was no significant difference in age and body height among three groups. In group A, body weight, percent of ideal body weight, and BMI were significantly lower than those in group B and C. Body weight of group B was not significantly different as compared with that of group C.
Pulmonary Function
In pulmonary function tests (Table 2) , VC, %VC, and FEV1 of group A were significantly lower than controls (r=0.656, p<0.001, r=0.575, p<0.05, respectively) (Fig 1) . Furthermore, PEmax significantly correlated with LEAN in patients with COPD (r=0.591, p<0.01) (Fig 2) . DISCUSSION Our results show that lean body mass change may be closely associated with decreased respiratory strength in patients with COPD. It is not known from the present study whether a similar relation exists in normal subjects or other conditions that result in decreased respiratory function. However, it appears to be the case at least in normal male subjects, because we found age-dependent decrease after age 40 years in respiratory muscle strength.9 This pattern appears to be very similar to that described in LEAN differences in Japanese young, middle-, and old-age male control subjects."1 Moreover, Plmax had a significant correlation with LEAN in normal control subjects. It is therefore conceivable that LEAN may well be a good indicator of respiratory muscle strength at least in patients with COPD and normal male subjects.
In patients with COPD, diaphragm muscle mass and thickness vary with body weight in a fashion similar to that in patients without COPD. In normalweight patients with COPD, diaphragm muscle mass, thickness, and area were within normal limits.1 Thurlbeck12 showed a similar linear relation between diaphragm and body weights in patients with emphysema. However, the functioning of the diaphragms of patients with stable COPD, whose body weight is not reduced, is as good as in normal subjects at the same lung volume. 13 In the present study, we also showed reduction in respiratory muscle strength in the patients with COPD with body weight loss but not in the patients without weight loss or in control subjects. These results suggested that the patients with COPD without body weight loss might still maintain their respiratory muscle mass and strength. FAT was significantly lower in group A as compared with groups B and C. It Pimax (cmH20) of the lungs, resulting in a decrease in tension produced by inspiratory muscle shortening. However, we could find no correlation between Plmax and RV. Moreover, there were no significant differences in both TLC and RV between the two groups with COPD. Therefore, decrease in respiratory muscle strength may be affected by factors other than air trapping.
The fact that acute hypercapnea can cause some interference with the development of maximal respiratory pressures has been shown in normal subjects.15 In the present study, there were no significant differences in variables of blood gas analysis between the two groups with COPD. The variables of blood gas analysis were not significantly correlated with respiratory muscle strength.
The limitation of the present study needs to be mentioned. This is not a longitudinal study but a cross-sectional study; therefore, we do not know how much body weight was "lost" during the long time course of COPD in our patients. Further prospective study is necessary to quantitatively assess the degree of body weight loss, LEAN loss, and the decreasing rate of respiratory muscle strength. Such a study is now underway in our hospital.
The clinical significance of the present study would be that if respiratory muscle weakness is closely related with a change in LEAN in patients with COPD, it may be possible that any efforts to preserve LEAN in these patients would retard the deterioration in respiratory muscle function in some way. Indeed, there are some reports that special nutritional intervention may benefit patients with COPD by improving pulmonary function.16 Much needs to be done before this approach proves useful, but our study provides a new approach to assessing body composition in clinical settings.
Lastly, this study provides a new aspect for the study of respiratory muscle function. Since the first measurement of respiratory muscle function was reported more than 20 years ago, extensive study has been reported. Recently, we reported Japanese normative data for Plmax and PEmax,9 Plmax in patients with heart failure,4 and Plmax in patients with neuromuscular disease.3 The present study continues our effort to elucidate what factors should influence respiratory muscle strength in various states. Respiratory muscle strength was significantly correlated with age, pulmonary function, cardiac output, and generalized muscle atrophy. Since various factors are responsible for respiratory muscle strength, a change in LEAN may exist in these conditions and may affect respiratory muscle function at least in part. The assessment of the changes in body composition, especially in LEAN, should be important to elucidate the mechanism of respiratory muscle weakness in various conditions. These results show that respiratory muscle strength is closely associated with body weight and LEAN in patients with COPD. The present approach to compare respiratory muscle strength with LEAN should be useful for studying the mechanism of respiratory muscle weakness in patients with COPD.
